Hudson Bay Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Hudson Bay Capital Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-60,000	Closed	-$4.09M	–	1397
2022 Q3	$4.09M	Buy	+60,000	New	+$3.31M	0.04%	481
2019 Q1	–	Sell	-30,000	Closed	-$1.23M	–	970
2018 Q4	$1.23M	Sell	30,000 -40,000	-57%	-$1.5M	0.02%	599
2018 Q3	$2.66M	Buy	+70,000	New	+$3.1M	0.03%	411
2017 Q4	–	Sell	-225,000	Closed	-$6.99M	–	571
2017 Q3	$6.99M	Buy	225,000 +125,000	+125%	+$3.52M	0.17%	114
2017 Q2	$2.73M	Buy	+100,000	New	+$2.98M	0.06%	293

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hudson Bay Capital Management's GBT Position: Q4 2022 in Review

Hudson Bay Capital Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 60,000 shares — an estimated $4.09M sold.

Hudson Bay Capital Management first reported a position in GBT in Q2 2017 and held it in 5 quarters. The position peaked at $6.99M in Q3 2017. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Hudson Bay Capital Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Hudson Bay Capital Management sold 60,000 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $4.09M.
Hudson Bay Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q2 2017 and held it in 5 quarters.
Hudson Bay Capital Management's Global Blood Therapeutics, Inc. position peaked at $6.99M in Q3 2017.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Hudson Bay Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.